中/EN Contact/Message
Policies
Lecheng Management Bureau and Raffles Medical Group have a discussion to explore the joint construction of an Asian medical window
Release time:2023-05-23
Views:282

Recently, Jia Ning, Secretary of the Party Committee and Director of the Lecheng Pioneer District Management Bureau, met with Dr. Xie Fengcai, President of Raffles Medical Group in China, and had in-depth exchanges on further deepening cooperation between the two sides and jointly building an Asian medical window.

Jia Ning welcomed the arrival of Xie Fengcai and his delegation, and introduced the latest situation and development opportunities of Lecheng Pilot Zone. He said that the Lecheng Pilot Zone is currently committed to creating a "platform highland" for the agglomeration and development of the medical industry. We welcome Raffles Medical and Lecheng to carry out more cooperation and exploration, actively participate in the construction of Lecheng Medical Industry Transformation Platform, International Multi center Medical Device Clinical Trial Platform, and jointly promote the innovative development of the biopharmaceutical industry.

Xie Fengcai expressed gratitude for the strong support provided by the Lecheng Management Bureau and introduced the progress of the Raffles (Hainan) Hospital project. He stated that the group will rely on Raffles (Hainan) Hospital to carry out deeper cooperation with Lecheng Pilot Zone in more fields such as industry, talent, academic exchange, and two-way drainage to jointly build an Asian medical window.

Liu Saifei, Senior Business Director of Raffles Medical Group in China, and Shi Juanjuan, Senior Operations Manager of Raffles (Hainan) Hospital, attended the symposium.

Extended reading:

Raffles Healthcare Group was established in 1976 and is the largest and authoritative private healthcare group in Singapore and Asia, located in 5 countries and 14 cities. We currently have 100 clinics and 4 comprehensive international hospitals. In 2022, Raffles (Hainan) Hospital officially started construction in the Lecheng pilot area and plans to open for trial operation in April this year.

As an international medical enterprise with a footprint throughout Southeast Asia and a solid brand and reputation foundation, Raffles Medical Group will fully utilize the policy advantages of the Free Trade Port and Lecheng Pilot Zone, leverage the strategic position of Hainan as the "international domestic dual circulation intersection", achieve two-way drainage of domestic and international patients, and provide professional and differentiated high-end medical services for patients in Lecheng.